{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:09:52Z","timestamp":1785798592530,"version":"3.56.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Thyroid carcinoma (THCA) has a low mortality rate, but its incidence has been rising over the years. We need to pay attention to its progression and prognosis. In this study, a transcriptome sequencing analysis and bioinformatics methods were used to screen key genes associated with THCA development and analyse their clinical significance and diagnostic value.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We collected 10 pairs of THCA tissues and noncancerous tissues, these samples were used for transcriptome sequencing to identify disordered genes. The gene expression profiles were obtained from the Gene Expression Omnibus (GEO) database. Comprehensive analysis of thyroid clinicopathological data using The Cancer Genome Atlas (TCGA). R software was used to carry out background correction, normalization and log2 conversion. We used quantitative real-time PCR (qRT\u2013PCR) and Western blot to determine differentially expressed genes (DEGs) expression in samples. We integrated the DEGs expression, clinical features and progression-free interval (PFI). The related functions and immune infiltration degree were established by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and single-sample Gene Set Enrichment Analysis (ssGSEA). The UALCAN database was used to analyse the methylation level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We evaluated DEGs between normal tissue and cancer. Three genes were identified: regulator of G protein signaling 8 (RGS8), diacylglycerol kinase iota (DGKI) and oculocutaneous albinism II (OCA2). The mRNA and protein expression levels of RGS8, DGKI and OCA2 in normal tissues were higher than those in THCA tissues. Better survival outcomes were associated with higher expression of RGS8 (HR=0.38, P=0.001), DGKI (HR=0.52, P=0.022), and OCA2 (HR=0.41, P=0.003). The GO analysis, KEGG analysis and GSEA proved that the coexpressed genes of RGS8, DGKI and OCA2 were related to thyroid hormone production and peripheral downstream signal transduction effects. The expression levels of RGS8, DGKI and OCA2 were linked to the infiltration of immune cells such as DC cells. The DNA methylation level of OCA2 in cancer tissues was higher than that in the normal samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>RGS8, DGKI and OCA2 might be promising prognostic molecular markers in patients with THCA and reveal the clinical significance of RGS8, DGKI and OCA2 in THCA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.964891","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T08:14:01Z","timestamp":1660724041000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets"],"prefix":"10.3389","volume":"13","author":[{"given":"Miaoyu","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanjia","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shounan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","article-title":"Evolving understanding of the epidemiology of thyroid cancer","volume":"48","author":"Seib","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-018-4479-z","article-title":"Overall survival of papillary thyroid carcinoma patients: A single-institution long-term follow-up of 5897 patients","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S249237","article-title":"Circular RNA CircPRMT5 accelerates proliferation and invasion of papillary thyroid cancer through regulation of miR-30c\/E2F3 axis","volume":"12","author":"Xue","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3578-9_6","article-title":"A practical guide to the cancer genome atlas (TCGA)","volume":"1418","author":"Wang","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An r package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: An integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.11.035","article-title":"The PGC1\u03b1\/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib\/doxorubicin treatment in hepatocellular carcinoma","volume":"163","author":"Wang","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clon.2010.05.004","article-title":"Thyroid cancer epidemiology and prognostic variables","volume":"22","author":"Sipos","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5b00351","article-title":"Distinct metabolomic profiles of papillary thyroid carcinoma and benign thyroid adenoma","volume":"14","author":"Xu","year":"2015","journal-title":"J Proteome Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S249237","article-title":"Circular RNA CircPRMT5 accelerates proliferation and invasion of papillary thyroid cancer through regulation of miR-30c\/E2F3 axis","volume":"12","author":"Xue","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.3390\/ijms21155272","article-title":"The potential of metabolomics in the diagnosis of thyroid cancer","volume":"21","author":"Coelho","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2007.09.005","article-title":"R4 RGS proteins: regulation of G-protein signaling and beyond","volume":"116","author":"Bansal","year":"2007","journal-title":"Pharmacol Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molbrainres.2003.11.014","article-title":"Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system","volume":"122","author":"Larminie","year":"2004","journal-title":"Brain Res Mol Brain Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1158\/1055-9965.EPI-10-0514","article-title":"High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer","volume":"20","author":"Wiechec","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.11.014","article-title":"Malnutrition in pancreatic ductal adenocarcinoma (PDA): Dietary pancreatic enzymes improve short-term health but stimulate tumor growth","volume":"188","author":"Zolghadri","year":"2018","journal-title":"Am J Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2021.04.012","article-title":"Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer","volume":"113","author":"Hu","year":"2021","journal-title":"Genomics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20180620","article-title":"Diacylglycerol kinase control of protein kinase c","volume":"476","author":"Merida","year":"2019","journal-title":"Biochem J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.49.32746","article-title":"The cloning and characterization of a novel human diacylglycerol kinase, DGKiota","volume":"273","author":"Ding","year":"1998","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.18632\/oncoscience.386","article-title":"In colonic \u03c1(0) (rho0) cells reduced mitochondrial function mediates transcriptomic alterations associated with cancer","volume":"4","author":"Penrose","year":"2017","journal-title":"Oncoscience"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00320","article-title":"Overexpression of DGKI in gastric cancer predicts poor prognosis","volume":"7","author":"Huang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/jca.47902","article-title":"Clinical significance of long non-coding RNA DUXAP8 and its protein coding genes in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104455","article-title":"DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide","volume":"9","author":"Etcheverry","year":"2014","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1034\/j.1600-0749.2001.140203.x","article-title":"The mouse p (pink-eyed dilution) and human p genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH","volume":"14","author":"Brilliant","year":"2001","journal-title":"Pigment Cell Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e08-07-0710","article-title":"Localization to mature melanosomes by virtue of cytoplasmic dileucine motifs is required for human OCA2 function","volume":"20","author":"Sitaram","year":"2009","journal-title":"Mol Biol Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.00846.x","article-title":"Pigmentation-related genes and their implication in malignant melanoma susceptibility","volume":"18","author":"Fernandez","year":"2009","journal-title":"Exp Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.258","article-title":"Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma","volume":"130","author":"Duffy","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq057","article-title":"Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival","volume":"102","author":"Azzato","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","author":"Vinay","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03059","article-title":"Dendritic cells and CD8 T cell immunity in tumor microenvironment","volume":"9","author":"Fu","year":"2018","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/jcp.29833","article-title":"Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12","volume":"236","author":"Jiang","year":"2021","journal-title":"J Cell Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","article-title":"Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib","volume":"150","author":"Zhou","year":"2016","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA Methylation and cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.964891\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T08:14:05Z","timestamp":1660724045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.964891\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2022.964891"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.964891","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"article-number":"964891"}}